Eli Lilly and Company (LLY) stock fundamentals

Valuation

Market cap

USD 1.15T

P/E (trailing)

43.23

P/E (forward)

28.56

PEG ratio

1.29

Price / sales

14.41

Price / book

33.89

EV / EBITDA

28.4x

Dividend yield

0.54%

Profitability

Gross margin

83.4%

Operating margin

54.2%

Net margin

33.5%

Return on equity

102.3%

Growth (year over year)

Revenue growth

47.7%

Earnings growth

26.2%

Balance sheet & cash flow

Total cash

USD 8.95B

Total debt

USD 54.91B

Free cash flow

USD 11.07B

Current ratio

1.35

Price range

52-week low

USD 809.63

52-week high

USD 1321.21

About Eli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for…

Employees: 50,000

Go deeper on LLY

The free Fundamentals tool adds multi-year revenue, earnings, margin, cash flow and debt history, P/E and valuation trends, Piotroski, Altman and Beneish health scores, and dividend history. Learn how to read them in how to analyse stock fundamentals.

Other popular stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Amazon (AMZN)Alphabet (GOOGL)Meta Platforms (META)Tesla (TSLA)Broadcom (AVGO)Berkshire Hathaway (BRK-B)JPMorgan Chase (JPM)Visa (V)Mastercard (MA)UnitedHealth (UNH)Exxon Mobil (XOM)Costco (COST)Walmart (WMT)Netflix (NFLX)AMD (AMD)Palantir (PLTR)Oracle (ORCL)Salesforce (CRM)Adobe (ADBE)Intel (INTC)Micron (MU)